Canadian Cannabis Company Betting Big On Beverages

Analysis originally distributed on March 14, 2018 By: Michael Vodicka of Cannabis Stock Trades

Cannabis beverages are quickly emerging as one of the fastest growing cannabis sub-industries.

For proof - look no further than Canopy Growth Corp (TWMJF), Canada's largest cannabis company.

Back in October, Canopy announced a groundbreaking $200 million investment from Constellation Brands (CONST), the third largest US beer distributor with Corona on the roster.

In the short run, news of the investment sent shares of Canopy soaring - jumping more than 100% in the next 10 weeks.

cannabis beverages

More importantly - the deal signaled an important shift in the Canadian cannabis industry. Continue reading "Canadian Cannabis Company Betting Big On Beverages"

My Plan For Another 30% Gain In 5 Days

Analysis originally distributed on March 7, 2018 By: Michael Vodicka of Cannabis Stock Trades

The Canadian cannabis sector scored another blockbuster win last week - and it led to a quick 30% gain for one of Canada's most promising young cannabis companies. If you missed the recent pop higher don't worry - I see this same pattern repeating itself at least a few more times in the next three months. Here's what is going on.

Cronos Group (CRON) is one of Canada's largest and most promising cannabis companies. Shares began trading on the Toronto Venture Stock Exchange in December of 2014. Since then, Cronos has delivered huge gains to shareholders, jumping more than 1400% from its IPO price of $.80.

That impressive performance helped Cronos make history last week when it became the first ever Canadian cannabis producer to trade on the US-based NASDAQ stock exchange. Continue reading "My Plan For Another 30% Gain In 5 Days"

Another 1,000% Gain For An Early CBD Leader?

Analysis originally distributed on February 14 2018 By: Michael Vodicka of Cannabis Stock Trades

PotNetwork Holdings (OTC:POTN) has been one of the best performing cannabis stocks in the last five weeks.

Despite a recent pullback with the broader cannabis sector, shares of the US-based CBD specialist are still up more than 1,000% in just the last five weeks, jumping from $0.06 on December 26 to $0.65 on February 13.

PotNetwork Holdings

Those are the kind of short-term gains that can have a serious impact on a shareholders financial profile.

If you missed out on the big move higher - don't worry - I see this same pattern repeating itself with a little-known, CBD specialist that just began trading on the Australian Stock Exchange in early January. Let's take a closer look. Continue reading "Another 1,000% Gain For An Early CBD Leader?"

Australian Cannabis Biotech Developing Cancer and Epilepsy Drugs

Analysis originally distributed on August 23, 2016 By: Michael Vodicka of Cannabis Stock Trades

MGC Pharmaceuticals (TSX:MXC, OTC:MGCLF) is a young cannabis biotech headquartered in Western Australia that specializes in pharmaceutical product research and development.

MGC

Australian cannabis stocks have been red hot for the last few months.

  • I added Australian-based Cann Group (ASX:CAN) to the members portfolio on July 31 and we're already up 70% in less than three weeks.
  • I added fellow Australian cannabis stock AusCann (OTC:ACNNF) to the member portfolio on June 6 and we're up 55%.

If you want to learn more about our member portfolio click here.

Although the company is incorporated and headquartered in Australia it also has operations in both Israel and Europe.

For example, MGC received two licenses from the Slovenian government to grow, process and trade Cannabis Sativa L (Hemp) and its products, including Cannabidoil (CBD) resin, in Europe.

The company's founders were leaders in Israel's growing medical cannabis industry. Continue reading "Australian Cannabis Biotech Developing Cancer and Epilepsy Drugs"

Warren Buffet Would Love This Cannabis Stock

Analysis originally distributed on July 27, 2017 By: Michael Vodicka of Cannabis Stock Trades

In early 2017 Forbes ranked Warren Buffett as the world’s second richest man with a net worth of $72 billion.

Unlike most other billionaires on the list, Buffett didn’t get rich from owning just one company. Berkshire Hathaway Inc. (NYSE:BRK.B) functioned like a giant mutual fund, investing in many companies from different industries all across the economy. That way, if one industry or company struggled, it wouldn’t crush Berkshire’s performance.

At the core, this is a lesson in diversification. Putting all your eggs in one basket can be risky.

That is particularly true in the cannabis sector. It is a super young industry and cannabis stocks can be quite volatile.

I want to share a cannabis stock that Warren Buffett would love. Continue reading "Warren Buffet Would Love This Cannabis Stock"